Tirz is an innovative peptide that is gaining recognition not only as an effective sugar support peptide, but also as a revolutionary weight loss aid. Thanks to cutting-edge technology, Tirz actively works on your body to support not only blood sugar control, but also the reduction of excess weight and body fat.

Sema is an innovative agent that mimics the action of the natural hormone GLP-1, which is secreted in the body after eating a meal. GLP-1 plays a key role in regulating blood sugar levels and reducing appetite, making Sema ideal not only for people with type 2 diabetes, but also for those who want to effectively reduce weight.

Reta is a cutting-edge, experimental peptide that is already revolutionizing approaches to obesity treatment. With its innovative triple action on GLP-1, GIP and glucagon receptors, Reta offers more comprehensive and effective results than peptides that act on a single receptor. If you’re looking for advanced support for weight loss and sugar management, Reta may be the answer you need.

Cagri is a breakthrough long-acting amylin analog that is revolutionizing the approach to weight loss and metabolism control. Its unique action involves activation of both amylin and calcitonin receptors, which triggers a strong satiety signal in the brain. Through this mechanism, Cagri effectively reduces appetite and helps control food intake, which promotes long-term and effective weight loss.

Mazdu is an innovative, multi-agonist peptide that is gaining recognition as an effective therapy for treating obesity and controlling blood glucose levels. Its powerful action on multiple receptors in the body puts it at the forefront of cutting-edge medical solutions such as thiothiazepatide and semaglutide. Studies show that Mazdu, combined with a proper diet and regular exercise, can significantly accelerate weight reduction while promoting metabolic regulation and hypertension control.

Survo is a breakthrough compound that is already gaining recognition as an innovative therapy to support metabolism, appetite regulation and blood sugar levels. With dual active actions on glucagon and GLP-1 receptors, Survo provides a wide range of health benefits that not only support weight loss, but also improve overall well-being.

CargiSema is an innovative, long-acting amylin analogue that has shown amazing results in clinical trials for weight reduction and caloric intake control. With its synergistic action on amylin receptors (AMYR) and calcitonin receptors (CTR), CargiSema offers exceptional support for those struggling with obesity and related metabolic diseases.